NORBIT – Award and exercise of restricted stock units
May 23, 2024 08:40 ET
|
NORBIT ASA
Trondheim, 23 May 2024 The Board of Directors of NORBIT ASA (the "Company") has resolved to award a total of 271,102 restricted stock units ("RSUs") to members of its executive management based on...
Form 8.3 - Keywords Studios plc
May 23, 2024 08:38 ET
|
Octopus Investments
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Form 8.3 - [MATTIOLI WOODS PLC - 22 05 2024] - (CGWL)
May 23, 2024 08:35 ET
|
Canaccord Genuity Wealth Limited
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label
May 23, 2024 08:32 ET
|
Yield10 Bioscience, Inc.
- EPA approved an amendment to the label of INTERLINE herbicideto include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN,...
Navios Maritime Holdings Inc.’s Tender Offer Deadline is midnight on June 7, 2024 to receive $4.75 in Cash for All Holders of ADSs (Series G & H)
May 23, 2024 08:30 ET
|
Navios Maritime Holdings, Inc.
GRAND CAYMAN, Cayman Islands, May 23, 2024 (GLOBE NEWSWIRE) -- Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”) today provided a reminder of its continuing previously announced...
Form 8.3 - [LOK'N STORE GROUP PLC - 22 05 2024] - (CGWL)
May 23, 2024 08:30 ET
|
Canaccord Genuity Wealth Limited
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts
May 23, 2024 08:30 ET
|
Mangoceuticals, Inc.
Dallas, TX, May 23, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and...
Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences
May 23, 2024 08:30 ET
|
Inozyme Pharma Inc.
BOSTON, May 23, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for...
IO Biotech to Present at Jefferies Global Healthcare Conference
May 23, 2024 08:30 ET
|
IO Biotech
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win®...
Injectable Drug Delivery Market is Expected to Reach $1139.4 billion | MarketsandMarkets™
May 23, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 23, 2024 (GLOBE NEWSWIRE) -- Injectable Drug Delivery market in terms of revenue was estimated to be worth $754.5 billion in 2024 and is poised to reach $1139.4 billion by 2029, growing...